Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01720810 · ClinicalTrials.gov registry record
Pacific Northwest Udall Center (PANUC) Clinical Core
A clinical trial of Parkinson Disease and Cognitive Impairment, sponsored by University of Washington.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT01720810 is a study of Parkinson Disease and Cognitive Impairment that is actively recruiting participants, run by University of Washington. The registered enrollment target is 2,000 participants, below the 5,320-participant average among 297 other Parkinson Disease trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01720810, a study of Parkinson Disease and Cognitive Impairment, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates cognitive impairment in subjects with Parkinson disease (PD) and similar neurological disorder through obtaining longitudinal clinical and neuropsychological data. The long term goal is to have a well-characterized subject population to contribute to our understanding of the natural history, diagnosis and ultimate treatment of cognitive impairment in patients with PD and similar disorders.
Conditions Studied
Study Locations (1)
Washington
- VA Puget Sound Health Care System - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2010-03 |
| Est. Completion | 2025-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01720810
The ClinicalTrials.gov registry entry for NCT01720810 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,320-participant average among 297 other Parkinson Disease trials with a reported enrollment target (62% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01720810 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT01720810 about?
NCT01720810 is a clinical study titled "Pacific Northwest Udall Center (PANUC) Clinical Core". This study evaluates cognitive impairment in subjects with Parkinson disease (PD) and similar neurological disorder through obtaining longitudinal clinical and neuropsychological data. The long term goal is to have a well-characterized subject population to contribute to our understanding of the nat...
What is the current status of trial NCT01720810?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2010-03. Estimated completion is 2025-10-31.
What conditions does trial NCT01720810 study?
This clinical trial studies the following conditions: Parkinson Disease, Cognitive Impairment.
Who is sponsoring clinical trial NCT01720810?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01720810 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
University of Delaware Parkinson's Disease Registry
RECRUITING
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.